Dublin, Feb. 01, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/9r8hbp/world_in_vitro) has announced the ...
Primary endpoint and key secondary endpoints metTLC599 demonstrated statistically significant improvement over placebo through ...
Company Merger with Seelos Therapeutics, Inc. Expected to Close in Fourth Quarter 2018 Apricus ...
